BusinessGroundbreaking Settlement on Behalf of Southern African Gold Miners Suffering From Silicosis & TuberculosisBy Nasdaq OMXMay 3, 2018, 1:04 PM UTC
BusinessOak Therapeutics Announces Results of Bioequivalence Study of Company’s Oral Dissolvable Strip for TuberculosisBy Nasdaq OMXOct 3, 2017, 1:00 PM UTC
BusinessCURE Pharmaceutical Subsidiary, Oak Therapeutics, Completes Critical Milestone in Phase 1 of NIH Grant to Develop Oral Dissolvable Strip for TuberculosisBy Nasdaq OMXAug 22, 2017, 3:19 PM UTC
BusinessRefugees Need to Be Vetted for Health Reasons as Well as Terrorist Connections, States the Association of American Physicians and Surgeons (AAPS)By Nasdaq OMXNov 3, 2016, 8:01 PM UTC
